Blood pressure medication recall expands as more chlorthalidone pills fail to dissolve

The FDA has widened a recall involving chlorthalidone, a medication used for blood pressure, after finding that additional bottles are tied to a problem with how the tablets dissolve. This is a quality issue related to tablet performance, not a matter of incorrect labeling or appearance.

Here's what to know

NBC Chicago reported that the FDA's expanded recall covers 13,567 bottles of chlorthalidone tablets made by Inventia Healthcare Limited, all with an April 2027 expiration date. The agency classified the action as Class II, meaning moderate risk, after determining that "the pills don't dissolve properly."

@nbcchicago

BLOOD PRESSURE MEDICATION RECALL: More bottles of the blood pressure medication Chlorthalidone have been recalled by the FDA because the pills don't dissolve properly. It's the second time this year the drug has been recalled. More than 11,4000 bottles of Chlorthalidone tablets were initially recalled earlier this year. Now, the FDA has expanded the recall to 13,567 bottles, with an expiration date of April 2027. The drug is manufactured by Inventia Healthcare Limited. The latest recall, the FDA says, is a Class II, which means the risk level is moderate.

♬ original sound - NBC Chicago

The expanded action follows an earlier recall involving more than 11,000 bottles of the same medication.

More background

Reaction in the comments on NBC Chicago's post went beyond this recall itself, with several users expressing broader distrust of prescription drugs and saying they had stopped taking medications altogether.

One commenter wrote, "I don't trust taking any blood pressure medication or any kind of prescription medications."

What's being done?

The main response is the recall itself. The FDA has expanded the number of affected bottles and identified the drug, manufacturer, and expiration date, giving pharmacies, distributors, and patients the information they need to determine whether their supply is included.

The next step is to check any chlorthalidone bottle on hand and verify whether it was made by Inventia Healthcare Limited and whether it carries the April 2027 expiration date named in the expanded recall. If it does, contacting the pharmacy or prescribing clinician is a more reliable step than relying on advice from the comments on NBC Chicago's post.

Where can I learn more?

These stories cover other FDA-linked drug recalls, a broader surge in consumer recalls, and research on medications that can raise heat risk.

• Breckenridge Pharmaceuticals recalled duloxetine after tests found a cancer-causing compound above acceptable limits.

• In the U.S., more than 2 million prednisolone bottles were recalled, but patients shouldn't stop abruptly.

• The FDA pulled nearly 900,000 epinephrine vials after labs flagged impurities and degradation in testing.

Get TCD's free newsletters for easy tips, smart advice, and a chance to earn $5,000 toward home upgrades. To see more stories like this one, change your Google preferences here.